{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:31:50Z","timestamp":1790937110834,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL149450"],"award-info":[{"award-number":["R01HL149450"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI158911"],"award-info":[{"award-number":["R01AI158911"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24AI143447"],"award-info":[{"award-number":["K24AI143447"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AI168436"],"award-info":[{"award-number":["P30AI168436"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tuberculosis necrotic granulomas contain triglyceride-rich macrophages (foam cells) with reduced antimicrobial functions. We assessed the ability of 2 compounds to reduce the triglyceride content and Mycobacterium tuberculosis (Mtb) burden in infected human monocyte-derived macrophages and in the lungs of Mtb-infected C3HeB\/FeJ mice: A-922500 (DGATi), an inhibitor of diacylglycerol O-acyltransferase 1, and LY2584702 (p70S6Ki), an inhibitor of p70 S6 kinase. DGATi and p70S6Ki significantly reduced the lipid content and bacillary burden in Mtb-infected macrophages. Each inhibitor reduced the cellular triglyceride content in bronchoalveolar lavage samples of Mtb-infected mice. After 6 weeks of treatment, p70S6Ki alone reduced the lung bacterial burden in Mtb-infected mice. However, DGATi alone and DGATi or p70S6Ki in combination with isoniazid did not reduce lung bacterial burden or alter lung inflammation. These findings provide further insight into the role of foam cells in tuberculosis pathogenesis and the utility of interventions targeting these cell populations as adjunctive host-directed therapies.<\/jats:p>","DOI":"10.1093\/infdis\/jiae577","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T14:44:23Z","timestamp":1732027463000},"page":"1141-1149","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacologic Inhibition of Macrophage Triglyceride Biosynthesis Pathways Does Not Improve <i>Mycobacterium tuberculosis<\/i> Control in Infected Mice"],"prefix":"10.1093","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4570-205X","authenticated-orcid":false,"given":"Jennie","family":"Ruelas Castillo","sequence":"first","affiliation":[{"name":"Department of Medicine"},{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Guerrini","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, Rutgers New Jersey Medical School, The State University of New Jersey , Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darla","family":"Quijada","sequence":"additional","affiliation":[{"name":"Department of Medicine"},{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-6075","authenticated-orcid":false,"given":"Styliani","family":"Karanika","sequence":"additional","affiliation":[{"name":"Department of Medicine"},{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranita","family":"Neupane","sequence":"additional","affiliation":[{"name":"Department of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"Urbanowski","sequence":"additional","affiliation":[{"name":"Internal Medicine Residency Program, National Capital Consortium, Walter Reed National Military Medical Center , Bethesda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3315-780X","authenticated-orcid":false,"given":"Babajide","family":"Shenkoya","sequence":"additional","affiliation":[{"name":"Center for Translational Medicine, School of Pharmacy, University of Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6314-6854","authenticated-orcid":false,"given":"Harley","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Medicine"},{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Garcia","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Addis","family":"Yilma","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Annunziata","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehan","family":"Khan","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, Rutgers New Jersey Medical School, The State University of New Jersey , Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2881-9870","authenticated-orcid":false,"given":"Mathangi","family":"Gopalakrishnan","sequence":"additional","affiliation":[{"name":"Center for Translational Medicine, School of Pharmacy, University of Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L","family":"Gennaro","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, Rutgers New Jersey Medical School, The State University of New Jersey , Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1338-9206","authenticated-orcid":false,"given":"Petros C","family":"Karakousis","sequence":"additional","affiliation":[{"name":"Department of Medicine"},{"name":"Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine , Baltimore, Maryland"},{"name":"Department of International Health"},{"name":"Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health , Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"2025060208125694500_jiae577-B1","author":"World Health Organization"},{"key":"2025060208125694500_jiae577-B2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41385-019-0226-5","article-title":"Therapeutic host-directed strategies to improve outcome in tuberculosis.","volume":"13","author":"Young","year":"2020","journal-title":"Mucosal Immunol"},{"key":"2025060208125694500_jiae577-B3","doi-asserted-by":"crossref","first-page":"e1000204","DOI":"10.1371\/journal.ppat.1000204","article-title":"Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M tuberculosis persistence.","volume":"4","author":"Peyron","year":"2008","journal-title":"PLoS Pathog"},{"key":"2025060208125694500_jiae577-B4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fimmu.2016.00434","article-title":"Granulomas and inflammation: host-directed therapies for tuberculosis.","volume":"7","author":"Ndlovu","year":"2016","journal-title":"Front Immunol"},{"key":"2025060208125694500_jiae577-B5","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3389\/fmicb.2020.01394","article-title":"Foam cells control Mycobacterium tuberculosis infection.","volume":"11","author":"Agarwal","year":"2020","journal-title":"Front Microbiol"},{"key":"2025060208125694500_jiae577-B6","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3389\/fimmu.2018.01490","article-title":"Necrosis driven triglyceride synthesis primes macrophages for inflammation during Mycobacterium tuberculosis infection.","volume":"9","author":"Jaisinghani","year":"2018","journal-title":"Front Immunol"},{"key":"2025060208125694500_jiae577-B7","doi-asserted-by":"crossref","first-page":"722735","DOI":"10.3389\/fimmu.2021.722735","article-title":"Inhibition of granuloma triglyceride synthesis imparts control of Mycobacterium tuberculosis through curtailed inflammatory responses.","volume":"12","author":"Dawa","year":"2021","journal-title":"Front Immunol"},{"key":"2025060208125694500_jiae577-B8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3389\/fimmu.2020.00910","article-title":"Mycobacterium tuberculosis infection-driven foamy macrophages and their implications in tuberculosis control as targets for host-directed therapy.","volume":"11","author":"Shim","year":"2020","journal-title":"Front Immunol"},{"key":"2025060208125694500_jiae577-B9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nri3211","article-title":"Revisiting the role of the granuloma in tuberculosis.","volume":"12","author":"Ramakrishnan","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2025060208125694500_jiae577-B10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.smim.2014.09.009","article-title":"The formation of the granuloma in tuberculosis infection.","volume":"26","author":"Orme","year":"2014","journal-title":"Semin Immunol"},{"key":"2025060208125694500_jiae577-B11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni.1781","article-title":"Foamy macrophages and the progression of the human tuberculosis granuloma.","volume":"10","author":"Russell","year":"2009","journal-title":"Nat Immunol"},{"key":"2025060208125694500_jiae577-B12","doi-asserted-by":"crossref","first-page":"ftw068","DOI":"10.1093\/femspd\/ftw068","article-title":"Macrophage form, function, and phenotype in mycobacterial infection: lessons from tuberculosis and other diseases.","volume":"74","author":"McClean","year":"2016","journal-title":"Pathog Dis"},{"key":"2025060208125694500_jiae577-B13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nri.2017.69","article-title":"Heterogeneity in tuberculosis.","volume":"17","author":"Cadena","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"2025060208125694500_jiae577-B14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201000079","article-title":"Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism.","volume":"2","author":"Kim","year":"2010","journal-title":"EMBO Mol Med"},{"key":"2025060208125694500_jiae577-B15","doi-asserted-by":"crossref","first-page":"e1007223","DOI":"10.1371\/journal.ppat.1007223","article-title":"Storage lipid studies in tuberculosis reveal that foam cell biogenesis is disease-specific.","volume":"14","author":"Guerrini","year":"2018","journal-title":"PLoS Pathog"},{"key":"2025060208125694500_jiae577-B16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1242\/dmm.019570","article-title":"Presence of multiple lesion types with vastly different microenvironments in C3HeB\/FeJ mice following aerosol infection with Mycobacterium tuberculosis.","volume":"8","author":"Irwin","year":"2015","journal-title":"Dis Model Mech"},{"key":"2025060208125694500_jiae577-B17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","article-title":"Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease.","volume":"8","author":"Panwar","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2025060208125694500_jiae577-B18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.immuni.2016.08.017","article-title":"mTORC1 and mTORC2 kinase signaling and glucose metabolism drive follicular helper T cell differentiation.","volume":"45","author":"Zeng","year":"2016","journal-title":"Immunity"},{"key":"2025060208125694500_jiae577-B19","doi-asserted-by":"crossref","first-page":"12297","DOI":"10.1074\/jbc.M900573200","article-title":"ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy.","volume":"284","author":"Ganley","year":"2009","journal-title":"J Biol Chem"},{"key":"2025060208125694500_jiae577-B20","doi-asserted-by":"crossref","first-page":"e1006874","DOI":"10.1371\/journal.ppat.1006874","article-title":"Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-\u03b3\/HIF-1\u03b1 signaling and supports host defense.","volume":"14","author":"Knight","year":"2018","journal-title":"PLoS Pathog"},{"key":"2025060208125694500_jiae577-B21","doi-asserted-by":"crossref","first-page":"dmm049018","DOI":"10.1242\/dmm.049018","article-title":"Rapamycin modulates pulmonary pathology in a murine model of Mycobacterium tuberculosis infection.","volume":"14","author":"Bhatt","year":"2021","journal-title":"Dis Model Mech"},{"key":"2025060208125694500_jiae577-B22","doi-asserted-by":"crossref","first-page":"e0104323","DOI":"10.1128\/aac.01043-23","article-title":"The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model.","volume":"68","author":"Ruelas Castillo","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"2025060208125694500_jiae577-B23","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis.","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"2025060208125694500_jiae577-B24","doi-asserted-by":"crossref","first-page":"102318","DOI":"10.1016\/j.tube.2023.102318","article-title":"Adaptation to the intracellular environment of primary human macrophages influences drug susceptibility of Mycobacterium tuberculosis.","volume":"139","author":"Lanni","year":"2023","journal-title":"Tuberculosis (Edinb)"},{"key":"2025060208125694500_jiae577-B25","doi-asserted-by":"crossref","first-page":"BSR20181822","DOI":"10.1042\/BSR20181822","article-title":"Rapamycin inhibits proliferation and induces autophagy in human neuroblastoma cells.","volume":"38","author":"Lin","year":"2018","journal-title":"Biosci Rep"},{"key":"2025060208125694500_jiae577-B26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/infdis\/jir786","article-title":"Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions.","volume":"205","author":"Harper","year":"2012","journal-title":"J Infect Dis"},{"key":"2025060208125694500_jiae577-B27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ejca.2013.11.039","article-title":"A phase I trial of LY2584702 tosylate, a p70 S6 kinase inhibitor, in patients with advanced solid tumours.","volume":"50","author":"Tolcher","year":"2014","journal-title":"Eur J Cancer"},{"key":"2025060208125694500_jiae577-B28","doi-asserted-by":"crossref","first-page":"e112027","DOI":"10.1371\/journal.pone.0112027","article-title":"Intestine-targeted DGAT1 inhibition improves obesity and insulin resistance without skin aberrations in mice.","volume":"9","author":"Tsuda","year":"2014","journal-title":"PLoS One"},{"key":"2025060208125694500_jiae577-B29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fmicb.2018.00070","article-title":"Harnessing the mTOR pathway for tuberculosis treatment.","volume":"9","author":"Singh","year":"2018","journal-title":"Front Microbiol"},{"key":"2025060208125694500_jiae577-B30","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1073\/pnas.0914798107","article-title":"Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis.","volume":"107","author":"Li","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025060208125694500_jiae577-B31","doi-asserted-by":"crossref","first-page":"13163","DOI":"10.1073\/pnas.1411571111","article-title":"Ghrelin promotes hepatic lipogenesis by activation of mTOR-PPAR\u03b3 signaling pathway.","volume":"111","author":"Li","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025060208125694500_jiae577-B32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11010-019-03625-5","article-title":"Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.","volume":"463","author":"Dong","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"2025060208125694500_jiae577-B33","doi-asserted-by":"crossref","first-page":"16184","DOI":"10.1073\/pnas.1213343109","article-title":"Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase.","volume":"109","author":"Owen","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025060208125694500_jiae577-B34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","article-title":"Activation of a metabolic gene regulatory network downstream of mTOR complex 1.","volume":"39","author":"D\u00fcvel","year":"2010","journal-title":"Mol Cell"},{"key":"2025060208125694500_jiae577-B35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tube.2008.11.001","article-title":"Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models.","volume":"89","author":"C\u00e1ceres","year":"2009","journal-title":"Tuberculosis (Edinb)"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae577\/61217030\/jiae577.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/5\/1141\/61217030\/jiae577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/5\/1141\/61217030\/jiae577.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:13:10Z","timestamp":1748866390000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/231\/5\/1141\/7904641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,11,19]]},"published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae577","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5,15]]},"published":{"date-parts":[[2024,11,19]]}}}